Regencell Bioscience

RGCNasdaq Hong Kong Health Care Medicinal Chemicals and Botanical Products

Market cap

$2.675 B

$5.41 -0.92%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$3.58M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products — ranked by market cap

All 26 →

#4Definium TherapeuticsDFTX$5.03B
#5RLX TechnologyRLX$3.11B
#6Regencell BioscienceRGC$2.68B
#7Trulieve CannabisTRLV$1.68B
#8Cronos GroupCRON$1.17B

Where these numbers come from

Share counts and financials for Regencell Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.